KR890011974A - 산화-민감성 화합물을 함유하는 안정한 혼합물, 이의 제조방법 및 산화-민감성 화합물을 안정화하기 위한 배합물의 용도 - Google Patents

산화-민감성 화합물을 함유하는 안정한 혼합물, 이의 제조방법 및 산화-민감성 화합물을 안정화하기 위한 배합물의 용도 Download PDF

Info

Publication number
KR890011974A
KR890011974A KR1019890000932A KR890000932A KR890011974A KR 890011974 A KR890011974 A KR 890011974A KR 1019890000932 A KR1019890000932 A KR 1019890000932A KR 890000932 A KR890000932 A KR 890000932A KR 890011974 A KR890011974 A KR 890011974A
Authority
KR
South Korea
Prior art keywords
oxidation
vitamin
mixture according
sensitive compounds
sensitive
Prior art date
Application number
KR1019890000932A
Other languages
English (en)
Inventor
찌하루 후카마찌
슈마커 호스트
베베르트 볼프강
슈나이더 요아힘
Original Assignee
후가와 히데아끼
니신 바디쉐 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 후가와 히데아끼, 니신 바디쉐 가부시끼가이샤 filed Critical 후가와 히데아끼
Publication of KR890011974A publication Critical patent/KR890011974A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Fats And Perfumes (AREA)
  • Edible Oils And Fats (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

산화-민감성 화합물을 함유하는 안정한 혼합물, 이의 제조방법 및 산화-민감성 화합물을 안정화하기 위한 배합물의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (11)

  1. 산화-민감성 화합물, 트리글리세라이드, 착화제 및 피복제를 함유하는 안정한 혼합물.
  2. 제1항에 있어서, 부가적으로 산화방지제를 함유하는 혼합물.
  3. 제1항 또는 2항에 있어서, 트리글리세라이드가 식물성유인 혼합물.
  4. 제1항 내지 3항중 어느 한 항에 있어서, 착화제가 피트산, 인산, 메타-, 피로- 또는 폴리인산 또는 그의 염인 혼합물.
  5. 제1항 내지 4항중 어느 한 항에 있어서, 피복제가 필름 형성제(특히, 단백질), 당 또는 폴리삭카라이드(특히, 알라비아 고무, 알기네이트 또는 전분 유도체)인 혼합물.
  6. 제1항 내지 5항중 어느 한 항에 있어서, 산화-민감성 화합물이 지용성 비타민(특히, 비타민 A 또는 이의 에스테르, 비타민 A산, 비타민 E 또는 비타민 D), 카로티노이드, 방향 또는 향미제인 혼합물.
  7. 제1항 내지 6항중 어느 한 항에 있어서, 비타민 A 또는 이의 에스테르, 피트산, 식물성유 및 젤라틴을 함유하는 혼합물.
  8. 제1항 내지 7항중 어느 한 항에 있어서, 100 내지 600㎛ 범위의 입자크기를 갖는 과립 또는 분상 형태인 혼합물.
  9. 산화-민감성 화합물, 트리글리세라이드, 착화제 및 피복제로부터 분산액을 제조하고 이 분산액을 고체 물질로 전환시킴을 특징으로 하는, 제1항 내지 8항중 어느 한 항에 청구된 화합물의 제조방법.
  10. 제9항에 있어서, 수성 분산액을 제조하고, 건조시키며 과립화하거나 분화시키는 방법.
  11. 산화-민감성 화합물을 안정화하기 위해 트리글리세라이드, 착화제 및 피복제의 배합물을 사용하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019890000932A 1988-01-29 1989-01-28 산화-민감성 화합물을 함유하는 안정한 혼합물, 이의 제조방법 및 산화-민감성 화합물을 안정화하기 위한 배합물의 용도 KR890011974A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1723288 1988-01-29
JP63-17232 1988-01-29

Publications (1)

Publication Number Publication Date
KR890011974A true KR890011974A (ko) 1989-08-23

Family

ID=11938201

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890000932A KR890011974A (ko) 1988-01-29 1989-01-28 산화-민감성 화합물을 함유하는 안정한 혼합물, 이의 제조방법 및 산화-민감성 화합물을 안정화하기 위한 배합물의 용도

Country Status (10)

Country Link
US (1) US4929774A (ko)
EP (1) EP0326026B1 (ko)
KR (1) KR890011974A (ko)
CN (1) CN1023229C (ko)
CA (1) CA1331136C (ko)
DE (1) DE58901641D1 (ko)
DK (1) DK174663B1 (ko)
IL (1) IL88961A (ko)
IN (1) IN171845B (ko)
SU (1) SU1639425A3 (ko)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2610626B1 (fr) * 1987-02-09 1989-05-19 Oreal Nouveau systeme anti-oxydant a base d'un ester d'ascorbyle stabilise, contenant en association au moins un agent complexant et au moins un thiol, et compositions contenant un tel systeme anti-oxydant
JPH02124894A (ja) * 1988-11-01 1990-05-14 Sanwa Kagaku Kenkyusho Co Ltd フィチン酸安定化組成物
US5180747A (en) * 1989-02-28 1993-01-19 Nisshin Flour Milling Co., Ltd. Stabilized fat-soluble vitamin compositions
US5290605A (en) * 1989-06-29 1994-03-01 Niva Shapira Sun-exposure nutritional supporting composition
KR930006431B1 (ko) * 1990-10-11 1993-07-16 재단법인 한국화학연구소 약물의 미세캡슐화 방법
WO1994001074A1 (en) * 1992-07-13 1994-01-20 Shiseido Company, Ltd. Composition for dermatologic preparation
US5270063A (en) * 1992-08-03 1993-12-14 Kellogg Company Ready-to-eat cereal products enriched with beta-carotene
FR2703263B1 (fr) * 1993-03-31 1995-05-19 Rhone Poulenc Nutrition Animal Procédé de préparation de sphérules de principes actifs.
IL110139A0 (en) * 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
JPH07203950A (ja) * 1994-01-26 1995-08-08 Kanegafuchi Chem Ind Co Ltd 被覆されたファフィア・ロドチーマ酵母及びその造粒物
AUPM677594A0 (en) * 1994-07-12 1994-08-04 Daratech Pty Ltd Preservation of exposed underground plant structures
CA2217264A1 (en) * 1995-04-07 1996-10-10 Abbott Laboratories Calcium supplements and calcium containing beverages comprising vitamin d
US5817351A (en) * 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage
DE19518845A1 (de) * 1995-05-23 1996-11-28 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Phytinsäure
US5827904A (en) * 1996-09-27 1998-10-27 Hahn; David Medical implant composition
EP0984915A4 (en) 1997-04-04 2002-11-27 Henkel Corp LUTEINE ESTERS WITH HIGH BIOAVAILABILITY
US6007856A (en) * 1997-08-08 1999-12-28 The Procter & Gamble Company Oil-in-water dispersions of β-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid
US20020054914A1 (en) * 1999-02-03 2002-05-09 Tulin Morcol Compositions and methods for therapuetic agents complexed with calcium phosphate and encased by casein
US20020068090A1 (en) * 1999-02-03 2002-06-06 Bell Steve J. D. Calcium phosphate particles as mucosal adjuvants
US20040258763A1 (en) * 1999-02-03 2004-12-23 Bell Steve J.D. Methods of manufacture and use of calcium phosphate particles containing allergens
ATE276199T1 (de) 1999-02-03 2004-10-15 Biosante Pharmaceuticals Inc Methoden zur herstellung von therapeutische kalzium-phosphat partikeln
US6328995B1 (en) * 1999-09-24 2001-12-11 Basf Aktiengesellschaft Stable vitamin and/or carotenoid products in powder form and process for their production
JP4227409B2 (ja) * 2001-01-30 2009-02-18 サビンサ コーポレーション 安定なルテインおよびルテイン誘導体の組成物を得るためのプロセス
WO2006073503A1 (en) * 2001-02-27 2006-07-13 Biosante Pharmaceuticals, Inc. Therapeutic calcium phosphate particles for use in inhibiting expression of a gene
US20030185892A1 (en) * 2001-08-17 2003-10-02 Bell Steve J. D. Intraocular delivery compositions and methods
DE10300325A1 (de) 2003-01-09 2004-07-22 Hexal Ag Granulat mit öliger Substanz, Herstellungsverfahren und Tablette
CN1744827B (zh) 2003-01-31 2010-05-26 帝斯曼知识产权资产管理有限公司 包含类胡萝卜素的新颖的组合物
DE10311585A1 (de) 2003-03-14 2004-09-23 Basf Ag Wirkstoffhaltige Adsorbate
DE10325989A1 (de) * 2003-06-07 2005-01-05 Glatt Gmbh Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung
US7446101B1 (en) * 2003-12-12 2008-11-04 Bioactives, Llc Bioavailable carotenoid-cyclodextrin formulations for soft-gels and other encapsulation systems
US9247765B2 (en) * 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
RU2381813C2 (ru) 2004-03-22 2010-02-20 Зольвай Фармасьютиклз Гмбх Пероральные фармацевтические композиции на основе продуктов, содержащих липазы, прежде всего панкреатин, и пав
US7351424B2 (en) * 2004-07-22 2008-04-01 Bio Lut S.A. De C.V. Enhanced purity trans-lutein-ester compositions and methods of making same
TWI309984B (en) * 2004-07-30 2009-05-21 Wakunaga Pharma Co Ltd Composition for capsule coating, capsule coating, and capsule agent
US20090041812A1 (en) * 2004-11-01 2009-02-12 Bell Steve J D Therapeutic Calcium Phosphate Particles in Use for Aesthetic of Cosmetic Medicine, and Methods of Manufacture and Use
JP5140586B2 (ja) * 2005-07-29 2013-02-06 アボット プロダクツ ゲゼルシャフト ミット ベシュレンクテル ハフツング 滅菌パンクレアチン粉末の製法
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US20070065487A1 (en) * 2005-09-21 2007-03-22 Bio Lut S.A. De C.V. Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
ES2969807T3 (es) * 2016-03-24 2024-05-22 Basf Se Preparados de principios activos de múltiples fases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5614338B2 (ko) * 1973-05-31 1981-04-03
DE3135329A1 (de) * 1981-09-05 1983-03-24 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von trockenpulvern oxidationsempfindlicher substanzen
JPS59122424A (ja) * 1982-12-29 1984-07-14 Riken Vitamin Co Ltd ビタミンａ組成物およびその製造法
JPS59204696A (ja) * 1983-05-06 1984-11-20 三井製薬工業株式会社 酸化防止剤
JPS62111676A (ja) * 1985-11-12 1987-05-22 Nippon Oil & Fats Co Ltd 酸化防止製剤

Also Published As

Publication number Publication date
CN1036220A (zh) 1989-10-11
DK35589D0 (da) 1989-01-27
EP0326026A3 (en) 1990-11-14
SU1639425A3 (ru) 1991-03-30
DK174663B1 (da) 2003-08-18
CA1331136C (en) 1994-08-02
IN171845B (ko) 1993-01-23
DK35589A (da) 1989-07-30
US4929774A (en) 1990-05-29
IL88961A (en) 1992-07-15
EP0326026B1 (de) 1992-06-17
CN1023229C (zh) 1993-12-22
EP0326026A2 (de) 1989-08-02
DE58901641D1 (de) 1992-07-23
IL88961A0 (en) 1989-08-15

Similar Documents

Publication Publication Date Title
KR890011974A (ko) 산화-민감성 화합물을 함유하는 안정한 혼합물, 이의 제조방법 및 산화-민감성 화합물을 안정화하기 위한 배합물의 용도
JP4571736B2 (ja) 安定な粉末状のビタミンおよび／またはカロチノイド製品ならびにその製法
KR890012566A (ko) 두나리에라 조체함유 고형상 식품과 그 제조법
RU2008113843A (ru) Ферментный гранулят i, содержащий фитазу
GB1459740A (en) Cat food
CA2274467A1 (en) Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use
US2470281A (en) Preservative coatings for foods
ES2192243T3 (es) Emulsiones y polvos secos estables de mezclas de vitaminas liposolubles, su obtencion y empleo.
RU2003105240A (ru) Усовершенствованный способ твердого дражирования
US2508477A (en) Enriched foodstuffs
KR900017500A (ko) 스낵제품의 제조방법
KR890001461A (ko) 조미 조성물 및 그의 제조방법
IL119320A0 (en) Seasoning mixture for the frozen food industry
JPS59225114A (ja) ビタミンの保護
JPH02276551A (ja) 被覆製剤およびその用途
JPS63164863A (ja) 被覆有機酸及び有機酸塩製剤の製造方法
CA2388169A1 (en) Phospholipid composition and use of same
JP2765694B2 (ja) 酸化感受性化合物の安定な組成物
KR870009657A (ko) 조미 조성물의 제조방법
EP0907411B1 (en) Method for the encapsulation of liquids
JPS5549313A (en) Vitamin pharmaceutical and its preparation
EE200200468A (et) Meetod toiduainete maitsestamiseks ja toiduaine
JPS5635967A (en) Food-flavoring composition
JPS5648878A (en) Freezing of food
ES464337A1 (es) Un procedimiento para la preparacion de una premezcla de a- limento en particulas que contienen elementos minoritarios, pero esenciales, tales como una vacuna oral, una vitamina o un elemento traza.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application